{"name":"Universitätsklinikum Hamburg-Eppendorf","slug":"universit-tsklinikum-hamburg-eppendorf","ticker":"","exchange":"","domain":"","description":"The University Medical Center Hamburg-Eppendorf is the teaching hospital of the University of Hamburg and the largest hospital in Hamburg, Germany.","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Adjuvant Nivolumab and Ipilimumab","genericName":"Adjuvant Nivolumab and Ipilimumab","slug":"adjuvant-nivolumab-and-ipilimumab","indication":"Adjuvant treatment of melanoma (resected stage III/IV)","status":"phase_3"},{"name":"CMF Chemotherapy","genericName":"CMF Chemotherapy","slug":"cmf-chemotherapy","indication":"Breast cancer (adjuvant and metastatic settings)","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Cefuroxime 4,5g","genericName":"Cefuroxime 4,5g","slug":"cefuroxime-4-5g","indication":"Other","status":"marketed"},{"name":"ERVEBO® (rVSV∆G-ZEBOV-GP)","genericName":"ERVEBO® (rVSV∆G-ZEBOV-GP)","slug":"ervebo-rvsv-g-zebov-gp","indication":"Prevention of Ebola virus disease caused by Zaire ebolavirus (ZEBOV)","status":"phase_3"}]}],"pipeline":[{"name":"Adjuvant Nivolumab and Ipilimumab","genericName":"Adjuvant Nivolumab and Ipilimumab","slug":"adjuvant-nivolumab-and-ipilimumab","phase":"phase_3","mechanism":"Nivolumab and ipilimumab together block immune checkpoints (PD-1 and CTLA-4) to enhance anti-tumor T-cell responses in adjuvant settings.","indications":["Adjuvant treatment of melanoma (resected stage III/IV)","Adjuvant treatment of renal cell carcinoma (resected stage III/IV)"],"catalyst":""},{"name":"CMF Chemotherapy","genericName":"CMF Chemotherapy","slug":"cmf-chemotherapy","phase":"phase_3","mechanism":"CMF is a combination chemotherapy regimen that uses three cytotoxic agents to inhibit cancer cell division and induce apoptosis.","indications":["Breast cancer (adjuvant and metastatic settings)"],"catalyst":""},{"name":"Cefuroxime 4,5g","genericName":"Cefuroxime 4,5g","slug":"cefuroxime-4-5g","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ERVEBO® (rVSV∆G-ZEBOV-GP)","genericName":"ERVEBO® (rVSV∆G-ZEBOV-GP)","slug":"ervebo-rvsv-g-zebov-gp","phase":"phase_3","mechanism":"ERVEBO is a live attenuated recombinant vesicular stomatitis virus (rVSV) vaccine expressing Ebola virus glycoprotein that primes the immune system to recognize and respond to Ebola virus infection.","indications":["Prevention of Ebola virus disease caused by Zaire ebolavirus (ZEBOV)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9vSnB0OEhPMThlNkFjV0NHUHR6SDhPQ3JNSXB3Y3dYUnBIbThhUlJIVGpTb2pRelNtLWlTMWNfd2tKc1RjeGREX3ZpOHNPZElLUVIzQlJDb1dYMkNEbzNvWkI2SFNpUGdDelZueVQ1bnFyT0Y2a1hMZ2RR?oc=5","date":"2025-02-20","type":"pipeline","source":"Hamburg Business","summary":"UKE testing 3D-printed medication - Hamburg Business","headline":"UKE testing 3D-printed medication","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":3,"marketed":1},"enrichmentLevel":2,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}